HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Beginning Cash Balance (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Beginning Cash Balance came in at $71.3 million in Q2 2026, down 53.67% year-over-year from $154.0 million in Q2 2025, and down 53.67% quarter-over-quarter from $154.0 million in Q2 2025.

Analysis

HUTCHMED (China) (HMDCF) Beginning Cash Balance (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Beginning Cash Balance for 12 consecutive years, with $71.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Beginning Cash Balance fell 53.67% year-over-year to $71.3 million in Q2 2026; TTM through Jun 2026 was $71.3 million, a 53.67% decrease from a year earlier, with the FY2018 full-year figure at $85.3 million, up 7.34% from the prior year.
  • Beginning Cash Balance was $71.3 million for Q2 2026 at HUTCHMED (China), down from $154.0 million in the prior quarter.
  • Over five years, Beginning Cash Balance peaked at $377.5 million in Q2 2022 and troughed at $71.3 million in Q2 2026.
  • A 5-year average of $239.9 million and a median of $283.6 million in 2024 frame the typical range for Beginning Cash Balance.
  • Across the five-year window, Beginning Cash Balance soared 60.23% in 2022 and sank 53.67% in 2026, its largest moves.
  • Over 5 years, Beginning Cash Balance stood at $377.5 million in 2022, then slipped by 17.02% to $313.3 million in 2023, then slipped by 9.48% to $283.6 million in 2024, then tumbled by 45.71% to $154.0 million in 2025, then slumped by 53.67% to $71.3 million in 2026.
  • The last three Beginning Cash Balance figures came in at $71.3 million (Q2 2026), $154.0 million (Q2 2025), and $283.6 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.93 Bn 198.94 Bn 7.24 Bn
2 Gilead Sciences 181.03 Bn 177.85 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.73 Bn 124.87 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.26 Bn 74.27 Bn 3.93 Bn
5 Argenx Se 61.30 Bn 56.11 Bn 1.37 Bn
6 Moderna 54.88 Bn 49.75 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.05 Bn 30.74 Bn 992.69 Mn
8 Biogen 31.22 Bn 29.94 Bn 1.96 Bn
9 Roivant Sciences 29.91 Bn 29.91 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 71.33 Mn
Jun 30, 2025 153.96 Mn
Jun 30, 2024 283.59 Mn
Jun 30, 2023 313.28 Mn
Jun 30, 2022 377.54 Mn
Jun 30, 2021 235.63 Mn
Mar 31, 2021 235.63 Mn
Jun 30, 2020 121.16 Mn
Mar 31, 2020 121.16 Mn
Sep 30, 2019 86.04 Mn
Jun 30, 2019 86.04 Mn
Mar 31, 2019 86.04 Mn
Dec 31, 2018 85.27 Mn
Sep 30, 2018 85.27 Mn
Jun 30, 2018 85.27 Mn
Mar 31, 2018 85.27 Mn
Dec 31, 2017 79.43 Mn
Jun 30, 2017 79.43 Mn
Dec 31, 2016 31.94 Mn
Jun 30, 2016 31.94 Mn